InvestLog
CLDX logo

CLDX

Celldex Therapeutics, Inc.NASDAQHealthcare
$31.06-0.64%ClosedMarket Cap: $2.07B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-02Goldman Sachs—Neutral—
2026-02-26Stifel—Buy—
2025-12-17Barclays—Underweight—
2025-11-11Barclays—Underweight—
2025-09-17Canaccord Genuity—Buy—
2025-08-20Citigroup—Buy—
2025-08-20Wells Fargo—Overweight—
2025-08-20HC Wainwright & Co.—Buy—
2025-06-16HC Wainwright & Co.—Buy—
2025-05-09UBS—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-4.82$12.3M8
Sun Dec 31$-3.63$126.5M9
Mon Dec 31$-0.16$471.3M3
Tue Dec 31$4.15$890.9M3